These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9652512)

  • 1. Nuclear medicine in primary bone tumors.
    Focacci C; Lattanzi R; Iadeluca ML; Campioni P
    Eur J Radiol; 1998 May; 27 Suppl 1():S123-31. PubMed ID: 9652512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
    Buscombe JR; Holloway B; Roche N; Bombardieri E
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
    Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
    Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
    Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
    J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear medicine in diagnosis and therapy of bone and joint diseases.
    Riccabona G
    Nucl Med Rev Cent East Eur; 1999; 2(1):42-52. PubMed ID: 14601000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.
    Moog F; Kotzerke J; Reske SN
    J Nucl Med; 1999 Sep; 40(9):1407-13. PubMed ID: 10492357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
    Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
    Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
    AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.
    Bombardieri E; Setti L; Kirienko M; Antunovic L; Guglielmo P; Ciocia G
    Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):381-99. PubMed ID: 26337240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Accuracy of Planar and Evolution SPECT/CT Bone Imaging in Differentiating Benign from Metastatic Bone Lesions.
    Teyateeti A; Tocharoenchai C; Muangsomboon K; Komoltri C; Pusuwan P
    J Med Assoc Thai; 2017 Jan; 100(1):100-10. PubMed ID: 29911774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.
    Hurley C; McCarville MB; Shulkin BL; Mao S; Wu J; Navid F; Daw NC; Pappo AS; Bishop MW
    Pediatr Blood Cancer; 2016 Aug; 63(8):1381-6. PubMed ID: 27082077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of PET in the diagnosis and staging of lung cancer.
    Coates G; Skehan SJ
    Can Respir J; 1999; 6(2):145-52. PubMed ID: 10322097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer: role of SPECT and PET in imaging bone metastases.
    Ben-Haim S; Israel O
    Semin Nucl Med; 2009 Nov; 39(6):408-15. PubMed ID: 19801220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.